Advertisement

Journal of Cancer Research and Clinical Oncology

, Volume 138, Issue 10, pp 1679–1682 | Cite as

Intralymphatic delivery of platinum-based chemotherapeutics is possible: an experimental study

  • Murat ZorEmail author
  • Ibrahim Yildirim
  • Seref Basal
  • Halil Yaman
  • Mustafa Ozturk
  • Cem Hasan Irkilata
  • Serdar Goktas
  • Murat Dayanc
Original Paper

Abstract

Purpose

Systemic chemotherapy regimens with cisplatinum have been associated with several toxicities. Thus, a loco-regional therapy approach may greatly reduce the toxicity. For this purpose, we designed this experimental study to investigate whether local chemotherapeutic injection is superior to systemic cisplatinum injection for retroperitoneal lymph nodes.

Methods

A total of 48 male Wistar rats were included to the study. Rats were divided into six groups. In the first three groups, systemic applications of cisplatinum, carboplatinum and oxaliplatin were performed, respectively. In the last three, local administration of cisplatinum, carboplatinum and oxaliplatin was performed, respectively. One hour after the chemotherapeutic agent applications, retroperitoneal lymph nodes were dissected and platinum concentrations were analyzed.

Results

When compared with systemic route, achieving higher platinum concentrations in the local chemotherapeutic application groups was the most spectacular result of the study. Serum platinum concentrations were also lower in the local application groups than systemic ones. When we compared local and systemic applications between three chemotherapeutic agents, the most significant concentration difference was seen in carboplatinum group.

Conclusion

The results of this study demonstrate that intralymphatic delivery of cisplatinum, carboplatinum and oxaliplatin leads to higher drug concentrations in the retroperitoneal lymph nodes when compared with intravenous administration.

Keywords

Testicular neoplasms Endolymphatic injections Regional perfusion 

Notes

Conflict of interest

None.

References

  1. Basal S, Irkilata HC, Yildirim I, Sadir S, Korkmaz A, Zor M, Aydur E, Peker AF (2008) Retroperitoneal testicular lymph node mapping in rats: an experimental study. Urol Oncol 26(3):286–290PubMedCrossRefGoogle Scholar
  2. Belani CP (2004) Recent updates in the clinical use of platinum compounds for the treatment of lung, breast, and genitourinary tumors and myeloma. Semin Oncol 31(6 Suppl 14):25–33PubMedCrossRefGoogle Scholar
  3. Cai S, Xie Y, Bagby TR, Cohen MS, Forrest ML (2008) Intralymphatic chemotherapy using a hyaluronan-cisplatin conjugate. J Surg Res 147(2):247–252PubMedCrossRefGoogle Scholar
  4. Carrick S, Ghersi D, Wilcken N, Simes J. (2004) Platinum containing regimens for metastatic breast cancer. Cochrane Database Syst Rev (3):CD003374Google Scholar
  5. Fiorentino MV, Daniele O, Morandi P, Aversa SM, Ghiotto C, Paccagnella A, Fornasiero A (1988) Intrapericardial instillation of platin in malignant pericardial effusion. Cancer 62(9):1904–1906PubMedCrossRefGoogle Scholar
  6. Follezou JY, Fauchon F, Chiras J (1989) Intraarterial infusion of carboplatin in the treatment of malignant gliomas: a phase II study. Neoplasma 36(3):349–352PubMedGoogle Scholar
  7. Jacobs SC, Menashe DS (1990) Intraarterial chemotherapy for bladder cancer. Prog Clin Biol Res 350:101–106PubMedGoogle Scholar
  8. Jones RH, Vasey PA (2004) Testicular cancer–management of advanced disease. Lancet Oncol 5(3):146–147CrossRefGoogle Scholar
  9. Kasugai H, Kojima J, Tatsuta M, Tanaka S, Okuda S, Sasaki Y, Imaoka S, Fujita M (1988) Intra-arterial infusion and chemo-embolization therapy for hepatocellular carcinoma using lipiodol and cisplatin. Nippon Shokakibyo Gakkai Zasshi 85(2):207–216PubMedGoogle Scholar
  10. Llopis B, Gallego J, Mompo JA, Boronat F, Jimenez JF (1985) Thiotepa versus adriamycin versus cis-platinum in the intravesical prophylaxis of superficial bladder tumors. Eur Urol 11(2):73–78PubMedGoogle Scholar
  11. Mortimer JE, Taylor ME, Schulman S, Cummings C, Weymuller E Jr, Laramore G (1988) Feasibility and efficacy of weekly intraarterial cisplatin in locally advanced (stage III and IV) head and neck cancers. J Clin Oncol 6(6):969–975PubMedGoogle Scholar
  12. Opitz I, Lardinois D, Arni S, Hillinger S, Vogt P, Odermatt B, Rousson V, Weder W (2007) Local recurrence model of malignant pleural mesothelioma for investigation of intrapleural treatment. Eur J Cardiothorac Surg 31(5):773–778PubMedCrossRefGoogle Scholar
  13. Paiva MB, Bublik M, Castro DJ, Udewitz M, Wang MB, Kowalski LP, Sercarz J (2005) Intratumor injections of cisplatin and laser thermal therapy for palliative treatment of recurrent cancer. Photomed Laser Surg 23(6):531–535PubMedCrossRefGoogle Scholar
  14. Sersa G, Miklavcic D, Cemazar M, Rudolf Z, Pucihar G, Snoj M (2008) Electrochemotherapy in treatment of tumours. Eur J Surg Oncol 34(2):232–234PubMedCrossRefGoogle Scholar
  15. Zor M, Yildirim I. (2012) Retroperitoneal lymph node mapping with patent blue dye injection. Is testicular route feasible? Arch Clin Exp Surg. doi: 10.5455/aces.20120410111659

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Murat Zor
    • 1
    Email author
  • Ibrahim Yildirim
    • 1
  • Seref Basal
    • 1
  • Halil Yaman
    • 1
  • Mustafa Ozturk
    • 1
  • Cem Hasan Irkilata
    • 1
  • Serdar Goktas
    • 1
  • Murat Dayanc
    • 1
  1. 1.Gulhane Medical AcademyAnkaraTurkey

Personalised recommendations